Thu, September 3, 2020
Wed, September 2, 2020
Tue, September 1, 2020

Chris Howerton Initiated (BTAI) at Strong Buy and Held Target at $82 on, Sep 2nd, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-82-on-sep-2nd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Chris Howerton of Jefferies, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $82 on, Sep 2nd, 2020.

Chris has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Chris's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chris


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $175 on, Monday, August 17th, 2020
  • Geoff Meacham of "B of A Securities" Reiterated at Strong Buy with Increased Target to $63 on, Monday, July 13th, 2020